Akebia Therapeutics Inc/ US00972D1054 /
01.05.2024 22:00:00 | Diff. -0.0200 | Volumen | Geld01:51:49 | Brief01:51:49 | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
1.2400USD | -1.59% | 3.11 Mio. Umsatz: 3.76 Mio. |
1.2400Geld Vol: 2'000 | 1.2600Brief Vol: 4'200 | 1.3000 | 1.2400 |
GlobeNewswire
07:00
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resoluti...
GlobeNewswire
07:00
argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
GlobeNewswire
07:00
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
06:59
ING posts 1Q2024 net result of €1,578 million, with strong commercial performance
GlobeNewswire
06:45
CARBIOS and Hündgen enter supply agreement for world’s first PET biorecycling plant
GlobeNewswire
05:28
OKX Partners with Bitcoin Asia to Offer Bitcoin Ordinal Ticketing for Flagship Conference in Hong Ko...
GlobeNewswire
05:00
OKX Ventures Announces Lead Investment in Bedrock, A Multi-Asset Liquid Restaking Protocol
GlobeNewswire
05:00
GLOBE LIFE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed A...
GlobeNewswire
05:00
ARHAUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Arhaus, Inc. on Behalf of Arhaus Stockhol...
GlobeNewswire
04:33
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Perion Networ...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite